Serum Anti-Müllerian Hormone Levels Are Associated with Early Miscarriage in the IVF/ICSI Fresh Cycle

Overview

Journal BMC Pregnancy Childbirth

Publisher Biomed Central

Specialty Gynecology & Obstetrics

Date 2022 Apr 3

PMID 35366830

Authors

Xin Liu

Ying Han

Xinyan Wang

Yunshan Zhang

Aijun Du

Ruqiang Yao

Jiabei Lv

Haining Luo

Affiliations

Soon will be listed here.

Abstract

Background: Anti-Müllerian hormone (AMH) is used as a biomarker to estimate ovarian reserve. The relationship between AMH and early miscarriage of in vitro fertilization (IVF) is still inconclusive. This study aimed to explore whether serum AMH levels are associated with early miscarriage rates after in vitro fertilization/intracytoplasmic sperm injection (IVF/ICSI) with fresh embryo transfer (ET).

Methods: This retrospective cohort study included 2246 patients undergoing their first oocyte retrievals for IVF/ICSI with fresh embryos transferred to Tianjin Central Hospital of Gynecology Obstetrics between May 2018 and March 2020. The serum AMH levels of the patients were measured within 12 months before the IVF/ICSI cycles. All women were divided into a low-AMH group, medium-AMH group and high-AMH group. Binary logistic regression was applied to confirm whether the serum AMH level was associated with the risk of early miscarriage independent of potential confounders, such as age, body mass index (BMI), duration of infertility, main diagnosis, history of internal medicine diseases, number of oocytes retrieved and high-quality embryo rate.

Results: The early miscarriage rate was significantly lower in the medium-AMH group than in either the low-AMH or high-AMH group among young (< 35 years) women (P = 0.015). In women above 35 years of age, the early miscarriage rates in the three AMH groups were not significantly different. Young women with high serum AMH levels had a significantly higher risk of early miscarriage regardless of age or other potential confounders (adjusted odds ratio (OR) 2.382, 95% confidence interval (CI) 1.246 to 4.553, P = 0.009). The results remained similar after restricting the analysis to women without polycystic ovary syndrome (PCOS).

Conclusions: With a high AMH level, young women had a higher risk of early miscarriage than women with a medium AMH level in their first IVF/ICSI treatment. In young women, serum AMH levels were independently associated with the risk of early miscarriage after IVF-ET treatment. Serum AMH levels might be a valuable marker to estimate the risk of early miscarriage. It is worth noting to the clinical value of AMH.

Citing Articles

High anti-Müllerian hormone level as a predictor of poor pregnancy outcomes in women with polycystic ovary syndrome undergoing in vitro fertilization/intracytoplasmic sperm injection: a retrospective cohort study.

Zhao F, Wen D, Zeng L, Wang R, Wang D, Xu H Reprod Biol Endocrinol. 2025; 23(1):15.

PMID: 39875902 PMC: 11773973. DOI: 10.1186/s12958-025-01347-6.

Expression and clinical significance of miR-141-5p as a biomarker in the serum of patients with early spontaneous abortion.

Che X, Wang X, Wang L, Xu L, Zou L, Ma T Clinics (Sao Paulo). 2024; 79:100327.

PMID: 38330788 PMC: 10864754. DOI: 10.1016/j.clinsp.2024.100327.

ApoC3 is expressed in oocytes and increased expression is associated with PCOS progression.

Zhou J, Mo H, Feng Q, Li L, La J J Ovarian Res. 2023; 16(1):188.

PMID: 37689737 PMC: 10493025. DOI: 10.1186/s13048-023-01263-6.

High anti-Mullerian hormone level is adversely associated with cumulative live birth rates of two embryo transfers after the first initiated cycle in patients with polycystic ovary syndrome.

Su N, Zhan J, Xie M, Zhao Y, Huang C, Wang S Front Endocrinol (Lausanne). 2023; 14:1123125.

PMID: 37388214 PMC: 10305806. DOI: 10.3389/fendo.2023.1123125.

The Relationship Between Insulin Resistance and Obesity and Serum Anti-Mullerian Hormone Level in Chinese Women with Polycystic Ovary Syndrome: A Retrospective, Single-Center Cohort Study.

Zhao H, Zhou D, Liu C, Zhang L Int J Womens Health. 2023; 15:151-166.

PMID: 36778752 PMC: 9911904. DOI: 10.2147/IJWH.S393594.

References

Jakubowicz D, Iuorno M, Jakubowicz S, Roberts K, Nestler J . Effects of metformin on early pregnancy loss in the polycystic ovary syndrome. J Clin Endocrinol Metab. 2002; 87(2):524-9. DOI: 10.1210/jcem.87.2.8207. View

Pereira N, Setton R, Petrini A, Lekovich J, Elias R, Spandorfer S . Is anti-Müllerian hormone associated with IVF outcomes in young patients with diminished ovarian reserve?. Womens Health (Lond). 2016; 12(2):185-92. PMC: 5375045. DOI: 10.2217/whe.15.102. View

Smeenk J, Sweep F, Zielhuis G, Kremer J, Thomas C, Braat D . Antimüllerian hormone predicts ovarian responsiveness, but not embryo quality or pregnancy, after in vitro fertilization or intracyoplasmic sperm injection. Fertil Steril. 2006; 87(1):223-6. DOI: 10.1016/j.fertnstert.2006.06.019. View

Paulini F, Melo E . The role of oocyte-secreted factors GDF9 and BMP15 in follicular development and oogenesis. Reprod Domest Anim. 2011; 46(2):354-61. DOI: 10.1111/j.1439-0531.2010.01739.x. View

Cimadomo D, Fabozzi G, Vaiarelli A, Ubaldi N, Ubaldi F, Rienzi L . Impact of Maternal Age on Oocyte and Embryo Competence. Front Endocrinol (Lausanne). 2018; 9:327. PMC: 6033961. DOI: 10.3389/fendo.2018.00327. View

Hassold T, Hunt P . To err (meiotically) is human: the genesis of human aneuploidy. Nat Rev Genet. 2001; 2(4):280-91. DOI: 10.1038/35066065. View

Humm K, Dodge L, Wu L, Penzias A, Malizia B, Sakkas D . In vitro fertilization in women under 35: counseling should differ by age. J Assist Reprod Genet. 2015; 32(10):1449-57. PMC: 4615928. DOI: 10.1007/s10815-015-0570-7. View

Blazar A, Lambert-Messerlian G, Hackett R, Krotz S, Carson S, Robins J . Use of in-cycle antimüllerian hormone levels to predict cycle outcome. Am J Obstet Gynecol. 2011; 205(3):223.e1-5. DOI: 10.1016/j.ajog.2011.04.035. View

Dewailly D, Pigny P, Soudan B, Catteau-Jonard S, Decanter C, Poncelet E . Reconciling the definitions of polycystic ovary syndrome: the ovarian follicle number and serum anti-Müllerian hormone concentrations aggregate with the markers of hyperandrogenism. J Clin Endocrinol Metab. 2010; 95(9):4399-405. DOI: 10.1210/jc.2010-0334. View

10.

Morin S, Patounakis G, Juneau C, Neal S, Scott R, Seli E . Diminished ovarian reserve and poor response to stimulation in patients <38 years old: a quantitative but not qualitative reduction in performance. Hum Reprod. 2018; 33(8):1489-1498. DOI: 10.1093/humrep/dey238. View

11.

Tarasconi B, Tadros T, Ayoubi J, Belloc S, de Ziegler D, Fanchin R . Serum antimüllerian hormone levels are independently related to miscarriage rates after in vitro fertilization-embryo transfer. Fertil Steril. 2017; 108(3):518-524. DOI: 10.1016/j.fertnstert.2017.07.001. View

12.

Goswami M, Nikolaou D . Is AMH Level, Independent of Age, a Predictor of Live Birth in IVF?. J Hum Reprod Sci. 2017; 10(1):24-30. PMC: 5405643. DOI: 10.4103/jhrs.JHRS_86_16. View

13.

Zegers-Hochschild F, Nygren K, Adamson G, de Mouzon J, Lancaster P, Mansour R . The ICMART glossary on ART terminology. Hum Reprod. 2006; 21(8):1968-70. DOI: 10.1093/humrep/del171. View

14.

Magnus M, Wilcox A, Morken N, Weinberg C, Haberg S . Role of maternal age and pregnancy history in risk of miscarriage: prospective register based study. BMJ. 2019; 364:l869. PMC: 6425455. DOI: 10.1136/bmj.l869. View

15.

Lekamge D, Barry M, Kolo M, Lane M, Gilchrist R, Tremellen K . Anti-Müllerian hormone as a predictor of IVF outcome. Reprod Biomed Online. 2007; 14(5):602-10. DOI: 10.1016/s1472-6483(10)61053-x. View

16.

Kostrzewa M, Zyla M, Garnysz K, Kaczmarek B, Szyllo K, Grzesiak M . Anti-Müllerian hormone as a marker of abortion in the first trimester of spontaneous pregnancy. Int J Gynaecol Obstet. 2020; 149(1):66-70. DOI: 10.1002/ijgo.13104. View

17.

Te Velde E, Scheffer G, Dorland M, Broekmans F, Fauser B . Developmental and endocrine aspects of normal ovarian aging. Mol Cell Endocrinol. 1999; 145(1-2):67-73. DOI: 10.1016/s0303-7207(98)00171-3. View

18.

Morales H, Lopez G, Cortes D, Torres G, Hernandez H, Guiot M . Evaluation of the Anti-Müllerian Hormone and its Association with Embryo Quality in Advanced Reproductive Treatments in a Latin American Population. JBRA Assist Reprod. 2021; 26(1):50-52. PMC: 8769191. DOI: 10.5935/1518-0557.20210050. View

19.

Granger E, Tal R . Anti-Müllerian Hormone and Its Predictive Utility in Assisted Reproductive Technologies Outcomes. Clin Obstet Gynecol. 2019; 62(2):238-256. DOI: 10.1097/GRF.0000000000000436. View

20.

Preutthipan S, Amso N, Curtis P, Shaw R . Effect of maternal age on clinical outcome in women undergoing in vitro fertilization and embryo transfer (IVF-ET). J Med Assoc Thai. 1996; 79(6):347-52. View